Length of life gained with surgical treatment of prostate cancer: A population-based analysis

References

• Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011;364:1708–17.
   PubMed Web of Science ®Google Scholar
• Vickers A, Bennette C, Steineck G, Adami HO, Johansson JE, Bill-Axelson A, et al. Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial. Eur Urol 2012;62:204–9.
   PubMed Web of Science ®Google Scholar
• Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, et al. Mortality results from the Goteborg randomised population-based prostate-cancer screening trial. Lancet Oncol 2010;11:725–32.
   PubMed Web of Science ®Google Scholar
• Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 2012;366:981–90.
   PubMed Web of Science ®Google Scholar
• Heggestad T, Jonsson PM, Danneskiold-Samsoe B, Leisti S. [Prostate cancer in Scandinavia. Variations in practice and attitude to radical treatment]. Nord Med 1993;108:104–6.
   PubMedGoogle Scholar
• Roder MA, Brasso K, Christensen IJ, Johansen J, Langkilde NC, Hvarness H, et al. Survival after radical prostatectomy for clinically localised prostate cancer: a population-based study. BJU Int 2014;113:541–7.
   PubMed Web of Science ®Google Scholar
• D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280:969–74.
   PubMed Web of Science ®Google Scholar
• Engholm G, Hakulinen T, Gislum M, Tryggvadottir L, Klint A, Bray F, et al. Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol 2010;49:655–64.
   PubMed Web of Science ®Google Scholar
• Statistics Denmark. Life expectancy tables. Available from http://www.statistikbanken.dk/HISB8. Accessed 13 January 2013.
   Google Scholar
• Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004;23:51–64.
   PubMed Web of Science ®Google Scholar
• Finne P, Fallah M, Hakama M, Ciatto S, Hugosson J, de Koning H, et al. Lead-time in the European Randomised Study of Screening for Prostate Cancer. Eur J Cancer 2010;46:3102–8.
   PubMed Web of Science ®Google Scholar
• Outzen M, Brasso K, Martinussen N, Christensen J, Tjonneland A, Friis S, et al. Prostate cancer in Denmark 1978–2009: trends in incidence and mortality. Acta Oncol 2013;52:831–6.
   PubMed Web of Science ®Google Scholar
• Mukai TO, Bro F, Pedersen KV, Vedsted P. [Use of prostate-specific antigen testing]. Ugeskr Laeger 2010;172:696–700.
   PubMedGoogle Scholar
• Zincke H, Oesterling JE, Blute ML, Bergstralh EJ, Myers RP, Barrett DM. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 1994;152:1850–7.
   PubMed Web of Science ®Google Scholar
• Mathers MJ, Roth S, Klinkhammer-Schalke M, Gerken M, Hofstaedter F, Wilm S, et al. Patients with localised prostate cancer (t1–t2) show improved overall long-term survival compared to the normal population. J Cancer 2011;2:76–80.
   PubMedGoogle Scholar
• Dalton SO, Schuz J, Engholm G, Johansen C, Kjaer SK, Steding-Jessen M, et al. Social inequality in incidence of and survival from cancer in a population-based study in Denmark, 1994–2003: summary of findings. Eur J Cancer 2008;44:2074–85.
   PubMed Web of Science ®Google Scholar
• Zeliadt SB, Etzioni R, Ramsey SD, Penson DF, Potosky AL. Trends in treatment costs for localized prostate cancer: the healthy screenee effect. Med Care 2007;45:154–9.
   PubMedGoogle Scholar
• Karlsen RV, Larsen SB, Christensen J, Brasso K, Friis S, Tjonneland A, et al. PSA testing without clinical indication for prostate cancer in relation to socio-demographic and clinical characteristics in the Danish Diet, Cancer and Health Study. Acta Oncol 2013;52:1609–14.
   PubMed Web of Science ®Google Scholar
• Johansson JE, Andren O, Andersson SO, Dickman PW, Holmberg L, Magnuson A, et al. Natural history of early, localized prostate cancer. JAMA 2004;291:2713–19.
   PubMed Web of Science ®Google Scholar
• Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005;293:2095–101.
   PubMed Web of Science ®Google Scholar
• Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012;367:203–13.
   PubMed Web of Science ®Google Scholar
• Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. JAMA 1993;269:2650–8.
   PubMed Web of Science ®Google Scholar
• Beck JR, Kattan MW, Miles BJ. A critique of the decision analysis for clinically localized prostate cancer. J Urol 1994;152:1894–9.
   PubMedGoogle Scholar
• Kattan MW, Cowen ME, Miles BJ. A decision analysis for treatment of clinically localized prostate cancer. J Gen Intern Med 1997;12:299–305.
   PubMed Web of Science ®Google Scholar
• Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995;274:626–31.
   PubMed Web of Science ®Google Scholar
• Humpel N, Magee C, Jones SC. The impact of a cancer diagnosis on the health behaviors of cancer survivors and their family and friends. Support Care Cancer 2007;15:621–30.
   PubMed Web of Science ®Google Scholar
• Epstein JI, Allsbrook WCJr, Amin MB, Egevad LL. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005;29:1228–42.
   PubMed Web of Science ®Google Scholar
• Helpap B, Egevad L. The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens. Virchows Arch 2006;449:622–7.
   PubMed Web of Science ®Google Scholar